AstraZeneca Pharma India Limited
NSE: ASTRAZEN.NS0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- National Stock Exchange of India
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Bhavana Agrawal
- Employees
- 940
- Headquarters
- Bengaluru, India
- IPO year
- 2002
- Market cap
- ₹212.3B
- Website
- https://www.astrazeneca.in
Loading ASTRAZEN…
Loading profile data…Frequently asked questions about ASTRAZEN
What does AstraZeneca Pharma India Limited (ASTRAZEN.NS) do?
AstraZeneca Pharma India Limited, a biopharmaceutical company, manufactures, distributes, and markets pharmaceutical products in India and internationally. It manufactures and sells cardiovascular disease and diabetes medicines under the Brilinta, Betaloc, Crestor, Forxiga, Imdur, Kombiglyze XR, Onglyza, Seloken XL, Xigduo XR, and QTERN brands;...
Where does ASTRAZEN.NS trade?
AstraZeneca Pharma India Limited (ASTRAZEN.NS) trades on the National Stock Exchange of India.
What sector is ASTRAZEN.NS in?
AstraZeneca Pharma India Limited (ASTRAZEN.NS) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of AstraZeneca Pharma India Limited?
Bhavana Agrawal is the chief executive officer of AstraZeneca Pharma India Limited (ASTRAZEN.NS).
Where is AstraZeneca Pharma India Limited headquartered?
AstraZeneca Pharma India Limited is headquartered in India.
Does ASTRAZEN.NS pay a dividend?
Yes — AstraZeneca Pharma India Limited (ASTRAZEN.NS) paid a trailing twelve-month dividend of INR 32.00 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did ASTRAZEN.NS go public?
AstraZeneca Pharma India Limited (ASTRAZEN.NS) completed its initial public offering in 2002.